Skip to content

Scholar Rock SRRK Short-Term Investments

Short-Term Investments at other companies

Biogen logo
BiogenBIIB
$900M
PTC Therapeutics logo
PTC TherapeuticsPTCT
$1.06B+93.5%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$219.05M+6.7%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$625.17M+422%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$60.3M
Arrowhead Research logo
Arrowhead ResearchARWR
$1.6B+75.0%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's short-term investments?
Scholar Rock (SRRK) reported short-term investments of $49.4M in Q1 2026.
How has Scholar Rock's short-term investments changed year-over-year?
Scholar Rock's short-term investments decreased by 78.2% year-over-year, from $226.45M to $49.4M.
What is the long-term trend for Scholar Rock's short-term investments?
Over 5 years (2020 to 2025), Scholar Rock's short-term investments has grown at a -24.6% compound annual growth rate (CAGR), from $180.67M to $44.04M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.